Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Tretinoin Prophylaxis for Anti-EGFR Induced Skin Toxicity in Solid Tumors
NCT06358677Phase 2Recruiting
- Sponsor
- University of Utah
- Start
- Feb 2025
- Primary completion
- Jul 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tretinoin in acneiform rash, sponsored by University of Utah. Started Feb 2025; status: recruiting.
02
Drugs
tretinoin
03
Conditions
acneiform rash
Beyond the preview
Go deeper on NCT06358677.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06358677.